Literature DB >> 20660136

Ex Vivo kinetics of early and long-term multifunctional human leukocyte antigen E-specific CD8+ cells in volunteers immunized with the Ty21a typhoid vaccine.

Rosângela Salerno-Goncalves1, Rezwanul Wahid, Marcelo B Sztein.   

Abstract

T cells are likely to play an important role in the host defense against Salmonella enterica serovar Typhi, the causative agent of typhoid fever. We have shown that HLA-E can function as a restriction element for S. Typhi-specific CD8(+) T cells. Because of the potential importance of HLA-E-restricted CD8(+) responses in resistance to Salmonella infection, we characterized these responses and investigated their kinetics of appearance and persistence in volunteers immunized orally with the licensed attenuated Ty21a strain typhoid vaccine. Cells were obtained from volunteers before and at days 2, 4, 7, 10, 14, 28, 42, 56, 120, 180, 360, and 720 after immunization. An ex vivo multicolor staining panel including antibodies to CD107a and -b, interleukin-2, gamma interferon (IFN-gamma), and tumor necrosis factor alpha (TNF-alpha) was used to functionally assess memory T-cell subsets by flow cytometry. Increases in cytokine-secreting CD8(+) cells were observed in the T effector/memory (T(EM)) and CD45RA(+) T(EM) (T(EMRA)) subsets as early as 4 days after immunization and persisted, particularly in the T(EMRA) subset, up to 2 years after immunization. The majority of HLA-E-restricted CD8(+) cells 28 to 56 days after immunization coexpressed CD107, IFN-gamma, and TNF-alpha, showing characteristic features of multifunctional T cells. In summary, the multifunctionality and longevity of the HLA-E-restricted CD8 responses observed in this study highlight their significance in adaptive immunity to S. Typhi. Finally, this is the first demonstration, in either animals or humans, of the presence of long-term multifunctional HLA-E-restricted CD8(+) cells after immunization.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20660136      PMCID: PMC2944457          DOI: 10.1128/CVI.00234-10

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  40 in total

Review 1.  A structural perspective on MHC class Ib molecules in adaptive immunity.

Authors:  Lucy C Sullivan; Hilary L Hoare; James McCluskey; Jamie Rossjohn; Andrew G Brooks
Journal:  Trends Immunol       Date:  2006-07-21       Impact factor: 16.687

2.  Cell-mediated immune responses in humans after immunization with one or two doses of oral live attenuated typhoid vaccine CVD 909.

Authors:  Rezwanul Wahid; Rosangela Salerno-Gonçalves; Carol O Tacket; Myron M Levine; Marcelo B Sztein
Journal:  Vaccine       Date:  2006-11-03       Impact factor: 3.641

3.  Intracellular cytokine optimization and standard operating procedure.

Authors:  Laurie Lamoreaux; Mario Roederer; Richard Koup
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

Review 4.  Generation of gut-homing T cells and their localization to the small intestinal mucosa.

Authors:  Bengt Johansson-Lindbom; William W Agace
Journal:  Immunol Rev       Date:  2007-02       Impact factor: 12.988

Review 5.  The major histocompatibility complex class Ib molecule HLA-E at the interface between innate and adaptive immunity.

Authors:  L C Sullivan; C S Clements; J Rossjohn; A G Brooks
Journal:  Tissue Antigens       Date:  2008-11

6.  Generation of specific effector and memory T cells with gut- and secondary lymphoid tissue- homing potential by oral attenuated CVD 909 typhoid vaccine in humans.

Authors:  R Wahid; R Salerno-Gonçalves; C O Tacket; M M Levine; M B Sztein
Journal:  Mucosal Immunol       Date:  2008-07-02       Impact factor: 7.313

7.  Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines.

Authors:  Joseph D Miller; Robbert G van der Most; Rama S Akondy; John T Glidewell; Sophia Albott; David Masopust; Kaja Murali-Krishna; Patryce L Mahar; Srilatha Edupuganti; Susan Lalor; Stephanie Germon; Carlos Del Rio; Mark J Mulligan; Silvija I Staprans; John D Altman; Mark B Feinberg; Rafi Ahmed
Journal:  Immunity       Date:  2008-05-08       Impact factor: 31.745

8.  HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells.

Authors:  Michael R Betts; Martha C Nason; Sadie M West; Stephen C De Rosa; Stephen A Migueles; Jonathan Abraham; Michael M Lederman; Jose M Benito; Paul A Goepfert; Mark Connors; Mario Roederer; Richard A Koup
Journal:  Blood       Date:  2006-02-07       Impact factor: 22.113

Review 9.  Cell-mediated immunity and antibody responses elicited by attenuated Salmonella enterica Serovar Typhi strains used as live oral vaccines in humans.

Authors:  Marcelo B Sztein
Journal:  Clin Infect Dis       Date:  2007-07-15       Impact factor: 9.079

10.  Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8(+) T cell responses.

Authors:  Melissa L Precopio; Michael R Betts; Janie Parrino; David A Price; Emma Gostick; David R Ambrozak; Tedi E Asher; Daniel C Douek; Alexandre Harari; Giuseppe Pantaleo; Robert Bailer; Barney S Graham; Mario Roederer; Richard A Koup
Journal:  J Exp Med       Date:  2007-05-29       Impact factor: 14.307

View more
  42 in total

1.  Epitope specific T-cell responses against influenza A in a healthy population.

Authors:  Miloje Savic; Jennifer L Dembinski; Yohan Kim; Gro Tunheim; Rebecca J Cox; Fredrik Oftung; Bjoern Peters; Siri Mjaaland
Journal:  Immunology       Date:  2015-12-08       Impact factor: 7.397

2.  Cross-reactive multifunctional CD4+ T cell responses against Salmonella enterica serovars Typhi, Paratyphi A and Paratyphi B in humans following immunization with live oral typhoid vaccine Ty21a.

Authors:  Rezwanul Wahid; Stephanie Fresnay; Myron M Levine; Marcelo B Sztein
Journal:  Clin Immunol       Date:  2016-09-12       Impact factor: 3.969

Review 3.  Immunology of gut mucosal vaccines.

Authors:  Marcela F Pasetti; Jakub K Simon; Marcelo B Sztein; Myron M Levine
Journal:  Immunol Rev       Date:  2011-01       Impact factor: 12.988

Review 4.  Live Attenuated Human Salmonella Vaccine Candidates: Tracking the Pathogen in Natural Infection and Stimulation of Host Immunity.

Authors:  James E Galen; Amanda D Buskirk; Sharon M Tennant; Marcela F Pasetti
Journal:  EcoSal Plus       Date:  2016-11

5.  Unexpected heterogeneity of multifunctional T cells in response to superantigen stimulation in humans.

Authors:  Monica A McArthur; Marcelo B Sztein
Journal:  Clin Immunol       Date:  2012-12-20       Impact factor: 3.969

6.  Live oral Salmonella enterica serovar Typhi vaccines Ty21a and CVD 909 induce opsonophagocytic functional antibodies in humans that cross-react with S. Paratyphi A and S. Paratyphi B.

Authors:  Rezwanul Wahid; Shah J Zafar; Monica A McArthur; Marcela F Pasetti; Myron M Levine; Marcelo B Sztein
Journal:  Clin Vaccine Immunol       Date:  2014-01-15

7.  Differential functional patterns of memory CD4+ and CD8+ T-cells from volunteers immunized with Ty21a typhoid vaccine observed using a recombinant Escherichia coli system expressing S. Typhi proteins.

Authors:  Rosângela Salerno-Gonçalves; Hervé Tettelin; David Luo; Qin Guo; Matthew T Ardito; William D Martin; Anne S De Groot; Marcelo B Sztein
Journal:  Vaccine       Date:  2019-10-16       Impact factor: 3.641

8.  Reduced T regulatory cell response during acute Plasmodium falciparum infection in Malian children co-infected with Schistosoma haematobium.

Authors:  Kirsten E Lyke; Abdoulaye Dabo; Charles Arama; Modibo Daou; Issa Diarra; Amy Wang; Christopher V Plowe; Ogobara K Doumbo; Marcelo B Sztein
Journal:  PLoS One       Date:  2012-02-14       Impact factor: 3.240

9.  Head-to-head comparison of humoral immune responses to Vi capsular polysaccharide and Salmonella Typhi Ty21a typhoid vaccines--a randomized trial.

Authors:  Anu Kantele; Sari H Pakkanen; Riitta Karttunen; Jussi M Kantele
Journal:  PLoS One       Date:  2013-04-08       Impact factor: 3.240

10.  Impact of oral typhoid vaccination on the human gut microbiota and correlations with s. Typhi-specific immunological responses.

Authors:  Emiley A Eloe-Fadrosh; Monica A McArthur; Anna M Seekatz; Elliott F Drabek; David A Rasko; Marcelo B Sztein; Claire M Fraser
Journal:  PLoS One       Date:  2013-04-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.